Cargando…
CRM1 Inhibitors for Antiviral Therapy
Infectious diseases are a major global concern and despite major advancements in medical research, still cause significant morbidity and mortality. Progress in antiviral therapy is particularly hindered by appearance of mutants capable of overcoming the effects of drugs targeting viral components. A...
Autores principales: | Mathew, Cynthia, Ghildyal, Reena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487384/ https://www.ncbi.nlm.nih.gov/pubmed/28702009 http://dx.doi.org/10.3389/fmicb.2017.01171 |
Ejemplares similares
-
Editorial: Viral Interactions with the Nucleus
por: Walker, Erin J., et al.
Publicado: (2017) -
Respiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention?
por: Caly, Leon, et al.
Publicado: (2015) -
Small Molecule Inhibitors of CRM1
por: Ferreira, Bibiana I., et al.
Publicado: (2020) -
Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication
por: Mathew, Cynthia, et al.
Publicado: (2021) -
Rhinovirus and Cell Death
por: Kerr, Shannic-Le, et al.
Publicado: (2021)